A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.
about
The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.Synthesis of C-14 Labeled GABAA α2/α3 Selective Partial Agonists and the Investigation of Late-Occurring and Long-Circulating Metabolites of GABAA Receptor Modulator AZD7325.Population pharmacokinetic modelling to assess clinical drug-drug interaction between AZD7325 and midazolam.
P2860
A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A clinical study to assess CYP ...... vitro and in vivo comparison.
@ast
A clinical study to assess CYP ...... vitro and in vivo comparison.
@en
type
label
A clinical study to assess CYP ...... vitro and in vivo comparison.
@ast
A clinical study to assess CYP ...... vitro and in vivo comparison.
@en
prefLabel
A clinical study to assess CYP ...... vitro and in vivo comparison.
@ast
A clinical study to assess CYP ...... vitro and in vivo comparison.
@en
P2093
P2860
P1476
A clinical study to assess CYP ...... vitro and in vivo comparison.
@en
P2093
Dhaval Desai
Diansong Zhou
Jianrong Lin
Maria D Ribadeneira
Maria Sunzel
Mark A Smith
Scott W Grimm
P2860
P304
P356
10.1111/J.1365-2125.2011.04155.X
P407
P577
2012-07-01T00:00:00Z